Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial (Q40358058)
Jump to navigation
Jump to search
scientific article published on 27 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial |
scientific article published on 27 January 2017 |
Statements
1 reference
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial (English)
1 reference
Vincent Meininger
1 reference
Leonard H van den Berg
1 reference
Albert Ludolph
1 reference
Wim Robberecht
1 reference
Matthew C Kiernan
1 reference
Adriano Chio
1 reference
P Nigel Leigh
1 reference
Susanne Petri
1 reference
Angela Genge
1 reference
Seung H Kim
1 reference
Jeremy M Shefner
1 reference
Claude Desnuelle
1 reference
Karen E Morrison
1 reference
Diane Boswell
1 reference
Jane Temple
1 reference
Rajat Mohindra
1 reference
Matt Davies
1 reference
Jonathan Bullman
1 reference
Paul Rees
1 reference
Arseniy Lavrov
1 reference
NOG112264 Study Group
1 reference
27 January 2017
1 reference
1 reference
16
1 reference
3
1 reference
208-216
1 reference
Identifiers
1 reference
1 reference